Today: Today, BlackRock Advisors LLC Increases Position in Cantel Medical Corp. (CMN)

Today, BlackRock Advisors LLC Increases Position in Cantel Medical Corp. (CMN)

BlackRock Advisors LLC increased its position in shares of Cantel Medical Corp. (NYSE:CMN) by 52.6% during the second quarter, Holdings Channel reports. The fund owned 71,941 shares of the company’s stock after buying an additional 24,805 shares during the period. BlackRock Advisors LLC owned about 0.17% of Cantel Medical Corp. worth $4,945,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the stock. LS Investment Advisors LLC increased its position in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock worth $104,000 after buying an additional 106 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Cantel Medical Corp. by 0.7% in the second quarter. UBS Asset Management Americas Inc. now owns 23,099 shares of the company’s stock worth $1,588,000 after buying an additional 163 shares during the last quarter. PineBridge Investments L.P. increased its position in shares of Cantel Medical Corp. by 3.8% in the second quarter. PineBridge Investments L.P. now owns 4,548 shares of the company’s stock worth $312,000 after buying an additional 165 shares during the last quarter. Suntrust Banks Inc. increased its position in shares of Cantel Medical Corp. by 5.5% in the second quarter. Suntrust Banks Inc. now owns 5,949 shares of the company’s stock worth $408,000 after buying an additional 311 shares during the last quarter. Finally, Acrospire Investment Management LLC increased its position in shares of Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock worth $102,000 after buying an additional 500 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Shares of Cantel Medical Corp. (NYSE:CMN) opened at 75.90 on Tuesday. The stock’s 50 day moving average price is $77.95 and its 200-day moving average price is $71.30. Cantel Medical Corp. has a 12-month low of $55.01 and a 12-month high of $81.63. The company has a market cap of $3.14 billion, a PE ratio of 52.78 and a beta of 1.59.

Cantel Medical Corp. (NYSE:CMN) last released its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.11. The firm earned $179 million during the quarter. Cantel Medical Corp. had a net margin of 9.02% and a return on equity of 16.70%. The firm’s revenue was up 18.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.39 EPS. On average, equities research analysts forecast that Cantel Medical Corp. will post $1.98 earnings per share for the current year.

The company also recently announced a semiannual dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Tuesday, January 17th will be given a dividend of $0.07 per share. This is a positive change from Cantel Medical Corp.’s previous semiannual dividend of $0.06. The ex-dividend date is Thursday, January 12th. This represents a yield of 0.18%. Cantel Medical Corp.’s payout ratio is currently 8.33%.

A number of equities research analysts have recently weighed in on the company. Benchmark Co. set a $83.00 price target on Cantel Medical Corp. and gave the company a “buy” rating in a report on Saturday, October 1st. Needham & Company LLC assumed coverage on Cantel Medical Corp. in a report on Wednesday, August 24th. They set a “hold” rating on the stock.

In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 14,897 shares of the business’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $78.76, for a total transaction of $1,173,287.72. Following the completion of the transaction, the chairman now owns 3,190,111 shares of the company’s stock, valued at approximately $251,253,142.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ann E. Berman sold 1,453 shares of the business’s stock in a transaction on Friday, September 30th. The stock was sold at an average price of $77.56, for a total transaction of $112,694.68. Following the transaction, the director now directly owns 5,424 shares of the company’s stock, valued at approximately $420,685.44. The disclosure for this sale can be found here. Company insiders own 15.30% of the company’s stock.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Related posts

Leave a Comment